Thiotepa Riemser

Medicinal product

(Invented) name

Thiotepa Riemser

Active substance (s)

Tiotepa

Strength

15 mg

Pharmaceutical form

milteliai infuzinio tirpalo koncentratui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01AC01, Thiotepa

Marketing authorisation holder

Esteve Pharmaceuticals GmbH, Vokietija

Date of authorisation

2021-03-26

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Powder for concentrate for solution for infusion	1 vnt.
Tiotepa	15 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
106246	92347	1092347	flakonas	N1		Receptinis	EU/1/21/1536/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2021-03-26	Registruotas